Mahler, D. A., Ohar, J. A., Barnes, C. N., Moran, E. J., Pendyala, S., & Crater, G. D. (2019). Nebulized Versus Dry Powder Long-Acting Muscarinic Antagonist Bronchodilators in Patients With COPD and Suboptimal Peak Inspiratory Flow Rate. Chronic Obstr Pulm Dis.
استشهاد بنمط شيكاغوMahler, Donald A., Jill A. Ohar, Chris N. Barnes, Edmund J. Moran, Srikanth Pendyala, و Gelnn D. Crater. "Nebulized Versus Dry Powder Long-Acting Muscarinic Antagonist Bronchodilators in Patients With COPD and Suboptimal Peak Inspiratory Flow Rate." Chronic Obstr Pulm Dis 2019.
MLA استشهادMahler, Donald A., et al. "Nebulized Versus Dry Powder Long-Acting Muscarinic Antagonist Bronchodilators in Patients With COPD and Suboptimal Peak Inspiratory Flow Rate." Chronic Obstr Pulm Dis 2019.